In this video, Pablo Mozas, MD, PhD, Hospital Clinic Barcelona, Barcelona, Spain, briefly discusses the importance of genomics in follicular lymphoma (FL) and explains how further investigating the genomic landscape of this disease may help clinicians and researchers better understand why patients may relapse and have poor outcomes. Dr Mozas then comments on the challenges with predicting prognosis in FL and also highlights the value of further investigating the tumor microenvironment. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
